1. Home
  2. HNST vs DCTH Comparison

HNST vs DCTH Comparison

Compare HNST & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Honest Company Inc.

HNST

The Honest Company Inc.

HOLD

Current Price

$2.62

Market Cap

249.3M

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$8.90

Market Cap

323.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNST
DCTH
Founded
2012
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.3M
323.1M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
HNST
DCTH
Price
$2.62
$8.90
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$3.00
$22.00
AVG Volume (30 Days)
1.8M
521.4K
Earning Date
06-01-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.53
EPS
N/A
0.07
Revenue
$371,317,000.00
N/A
Revenue This Year
N/A
$37.57
Revenue Next Year
$7.31
$31.57
P/E Ratio
N/A
$126.71
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$8.12
52 Week High
$5.52
$18.23

Technical Indicators

Market Signals
Indicator
HNST
DCTH
Relative Strength Index (RSI) 59.70 39.73
Support Level $2.38 $8.90
Resistance Level $2.98 $10.60
Average True Range (ATR) 0.13 0.46
MACD 0.08 -0.05
Stochastic Oscillator 63.58 24.52

Price Performance

Historical Comparison
HNST
DCTH

About HNST The Honest Company Inc.

The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: